What to do when abnormalities of potassium occur in HF patients? Prof. Butler discusses the recommendations in guidelines and a recent practical guidance paper in JACC.
Watch the discussion by the expert faculty of the symposium with prof. Stefan Anker, prof. Andrew Coats and prof. Javed Butler.
Prof. Coats states that RAASi is the mainstay of HFrEF therapy, but that elevated potassium levels in HF patients may be perceived as a barrier for optimal RAASi dosing.
Hyperkalemia is a major clinical problem. Prof. Stefan Anker talks about problems and risk associated with hyperkalemia.
Slides as educational service to PACE members and meeting participants.
Slides as educational service to PACE members and meeting participants.
Slides as educational service to PACE members and meeting participants.